The FDA has announced a nationwide recall of blood pressure medication, specifically chlorthalidone, due to a failure to meet dissolution specifications. More than 13,000 bottles have been affected, prompting health officials to issue alerts for patients to check their cabinets. The recall has been classified as a Class II risk, indicating that the medication may cause temporary or medically reversible adverse health consequences. This marks a significant response from the FDA to ensure patient safety amid ongoing quality testing failures.